Pernicious anemia during peginterferon-α2b plus ribavirin therapy for chronic hepatitis C

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 5, 2009, Pages 593-594

  Musialik, Joanna ^a   Petelenz, Michał ^a   Błoñska Fajfrowska, Barbara ^a   Hartleb, Marek ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESOPHAGOGASTRODUODENOSCOPY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; LIVER BIOPSY; MACROCYTIC ANEMIA; MALE; PERNICIOUS ANEMIA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANEMIA, PERNICIOUS; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 67651176352     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328326caf3     Document Type: Letter

References (5)

1. Hoofnagle J, Seeff L. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006; 355:2444-2451.
2. Borgia G, Reynaud L, Gentile I, Borrelli F, Cerini R, Ciampi R, et al. Pernicious anemia during INF-a treatment for chronic hepatitis C. J Interferon Cytokine Res 2003; 23:11-12. (Pubitemid 36308057)
3. Andreas E, Loukili N, Abdelghani M, Noel E. Pernicious anemia associated with interferon-a therapy for chronic hepatitis C. J Clin Gastroenterol 2004; 38:382.
4. Willson R. Interferon alfa-induced pernicious anemia in chronic hepatitis C infection. J Clin Gastroenterol 2001; 33:426-427. (Pubitemid 33026736)
5. Floreani A, Chiaramonte M, Greggio N, Fabris P, De Lazzari F, Naccarato R, et al. C Organ specific autoimmunity and genetic predisposition in interferontreated HCV-related chronic hepatitis patients. Ital J Gastroenterol Hepatol 1998; 30:71-76. (Pubitemid 28220704)